Transcend Wealth Collective, LLC

SEC CIK: 0001776082
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by Transcend Wealth Collective, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overview All 13F holders of BBIO Full Q2 2026 holdings

Shares (Q4 2024): 0; Sold out in Q4 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2024

Holdings of BBIO by Transcend Wealth Collective, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2024	0	$0	0.0%	−13,350−100.0%	Sold out	Holders
Q3 2024	13,350	$339.9K	<0.1%	−150−1.1%	Reduced	Holders
Q2 2024	13,500	$342.0K	<0.1%	+13,500	New	Holders